PlainRecalls
FDA Drug Moderate Class II Ongoing

Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.

Reported: July 2, 2025 Initiated: May 23, 2025 #D-0473-2025

Product Description

Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.

Reason for Recall

Presence of foreign tablets/capsules.

Details

Units Affected
36612 cartons
Distribution
USA Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Metoclopramide Tablets, USP 10 mg, 100-count bottle, Rx only, Manufactured in Croatia by Pliva Hrvatska, d.o.o., Zageb, Croatia, Manufactured for Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 0093-2203-01.. Recalled by Teva Pharmaceuticals USA, Inc. Units affected: 36612 cartons.
Why was this product recalled?
Presence of foreign tablets/capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 2, 2025. Severity: Moderate. Recall number: D-0473-2025.